Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Xetra  >  Merck KGaA    MRK   DE0006599905

Real-time Quote. Real-time Tradegate - 08/26 08:44:51 am
95.202 EUR   -0.14%
08/19 MERCK : EMD Serono Receives CEO Cancer Gold Standard ReAccreditation
08/16 MERCK : Millipore teams with TEAM Jaffrey
08/04DJMERCK KGAA : Lifts Profit Outlook as Sales Jump -- Update
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
08/19/2016 08/22/2016 08/23/2016 08/24/2016 08/25/2016 Date
96.84(c) 96.66(c) 97.01(c) 96.94(c) 95.34(c) Last
350 619 320 150 199 561 192 271 393 325 Volume
+0.44% -0.19% +0.36% -0.07% -1.65% Change
More quotes
Financials (€)
Sales 2016 15 085 M
EBIT 2016 3 275 M
Net income 2016 1 620 M
Debt 2016 10 926 M
Yield 2016 1,29%
Sales 2017 15 488 M
EBIT 2017 3 402 M
Net income 2017 1 795 M
Debt 2017 8 972 M
Yield 2017 1,39%
P/E ratio 2016 23,82
P/E ratio 2017 21,95
EV / Sales2016 1,54x
EV / Sales2017 1,37x
Capitalization 12 322 M
More Financials
Company
Merck KGaA engages in the manufacturing of pharmaceutical and chemical products.It operates through the following segments: Healthcare, Life Science, and Performance Materials.The Healthcare segment comprises of the businesses that were reported separately as the Merck Serono and Consumer Health... 
Sector
Pharmaceuticals
Calendar
09/20 | 02:45pmPresentation
More about the company
Surperformance© ratings of Merck KGaA
Trading Rating : Investor Rating :
More Ratings
Latest news on MERCK KGAA
08/25 MERCK : EMD Serono Receives CEO Cancer Gold Standard Re-Accreditation
08/19 MERCK : EMD Serono Receives CEO Cancer Gold Standard ReAccreditation
08/18 MERCK : Presolicitation Notice - Notice of Intent to Sole Source - EMD Millipore..
08/16 MERCK : Millipore teams with TEAM Jaffrey
08/15 DGAP-PVR : Merck KGaA: Release according to Article 26, Section 1 of the WpHG w..
08/15 DGAP-PVR : Merck KGaA: Veröffentlichung gemäß § 26 Abs. 1 WpHG mit dem Ziel der ..
08/14 MERCK : SAFC y Stars participaron en el 2016 Team Up Day of Service
08/07 MERCK : Check out some of the numbers behind Greg Cochrane's career
08/04DJMERCK KGAA : Lifts Profit Outlook as Sales Jump -- Update
08/04DJMERCK KGAA : Lifts Profit Outlook as Sales Jump
More news
Sector news : Specialty & Advanced Pharmaceuticals
08/25 FTSE retreats as pharma stocks fall
08/25DJStocks Fall as Investors Look to Fed's Jackson Hole Meeting
08/25DJStocks Fall as Investors Look to Fed's Jackson Hole Meeting
08/25DJStocks Fall as Investors Look to Fed's Jackson Hole Meeting -- 3rd Update
08/25DJMylan Boosts Price Assistance for EpiPen Amid Backlash
More sector news : Specialty & Advanced Pharmaceuticals
4-Traders Strategies on MERCK KGAA 
2014Prices move higher as positive news are released
2014A gap-filling is anticipated
More Strategies
News from SeekingAlpha
08/19 ALPHA FROM EQUAL-WEIGHTING : A Look At Materials
08/10 Bristol's Opdivo Fall-Out Brings Others Into Play
08/05 Merck KGaA's (MKGAF) CEO Stefan Oschmann on Q2 2016 Results - Earnings Call T..
08/04 Merck KGaA reports Q2 results
07/18 Merck's marketing application for Cladribine tablets accepted for review in E..
Advertisement
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MRK | DE0006599905 | 4-Traders
Full-screen chart
Technical analysis trends MERCK KGAA
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 104 €
Spread / Average Target 9,2%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Stefan Oschmann Chief Executive Officer
Wolfgang Heinz Büchele Chairman-Supervisory Board
Marcus Kuhnert Chief Financial Officer
Laszlo Radvanyi Senior Vice President & Head-Research
Crocifissa Attardo Member-Supervisory Board
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
MERCK KGAA8.23%14 125
ABBVIE INC9.25%105 953
BIOGEN INC0.16%67 781
KYOWA HAKKO KIRIN CO L..-22.41%8 641
MALLINCKRODT PLC0.82%8 524
JAZZ PHARMACEUTICALS P..-9.39%7 867
More Results